Annual EBIT
-$62.56 M
-$3.96 M-6.76%
31 December 2023
Summary:
Silence Therapeutics annual earnings before interest & taxes is currently -$62.56 million, with the most recent change of -$3.96 million (-6.76%) on 31 December 2023. During the last 3 years, it has fallen by -$16.32 million (-35.30%). SLN annual EBIT is now -4147.95% below its all-time high of -$1.47 million.SLN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$28.05 M
-$6.27 M-28.82%
01 September 2024
Summary:
Silence Therapeutics quarterly earnings before interest & taxes is currently -$28.05 million, with the most recent change of -$6.27 million (-28.82%) on 01 September 2024. Over the past year, it has dropped by -$14.56 million (-107.93%). SLN quarterly EBIT is now -559.72% below its all-time high of -$4.25 million, reached on 31 March 2024.SLN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$72.74 M
-$14.56 M-25.02%
01 September 2024
Summary:
Silence Therapeutics TTM earnings before interest & taxes is currently -$72.74 million, with the most recent change of -$14.56 million (-25.02%) on 01 September 2024. Over the past year, it has dropped by -$13.30 million (-22.37%). SLN TTM EBIT is now -497.49% below its all-time high of -$12.17 million, reached on 30 September 2020.SLN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.8% | -107.9% | -22.4% |
| 3 y3 years | -35.3% | -69.7% | -12.5% |
| 5 y5 years | -128.4% | - | - |
SLN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.3% | +0.8% | -559.7% | at low | -44.5% | at low |
| 5 y | 5 years | -128.4% | +0.8% | -559.7% | at low | -497.5% | at low |
| alltime | all time | -4147.9% | +0.8% | -559.7% | at low | -497.5% | at low |
Silence Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$28.05 M(+28.8%) | -$72.74 M(+25.0%) |
| June 2024 | - | -$21.77 M(+412.1%) | -$58.18 M(+15.6%) |
| Mar 2024 | - | -$4.25 M(-77.2%) | -$50.32 M(-16.7%) |
| Dec 2023 | -$62.56 M(+6.8%) | -$18.67 M(+38.4%) | -$60.43 M(+1.7%) |
| Sept 2023 | - | -$13.49 M(-3.1%) | -$59.44 M(+4.5%) |
| June 2023 | - | -$13.91 M(-3.1%) | -$56.89 M(-4.9%) |
| Mar 2023 | - | -$14.36 M(-18.8%) | -$59.85 M(+2.6%) |
| Dec 2022 | -$58.60 M(-7.1%) | -$17.68 M(+61.7%) | -$58.33 M(+4.4%) |
| Sept 2022 | - | -$10.94 M(-35.2%) | -$55.89 M(-9.1%) |
| June 2022 | - | -$16.87 M(+31.4%) | -$61.48 M(-1.4%) |
| Mar 2022 | - | -$12.84 M(-15.7%) | -$62.37 M(-0.1%) |
| Dec 2021 | -$63.08 M(+36.4%) | -$15.24 M(-7.8%) | -$62.40 M(-3.5%) |
| Sept 2021 | - | -$16.53 M(-6.9%) | -$64.68 M(+7.2%) |
| June 2021 | - | -$17.76 M(+38.0%) | -$60.33 M(+41.7%) |
| Mar 2021 | - | -$12.87 M(-26.5%) | -$42.56 M(+43.4%) |
| Dec 2020 | -$46.24 M(+58.6%) | -$17.52 M(+43.9%) | -$29.69 M(+143.9%) |
| Sept 2020 | - | -$12.17 M | -$12.17 M |
| Dec 2019 | -$29.16 M(+6.5%) | - | - |
| Dec 2018 | -$27.39 M(+464.1%) | - | - |
| Dec 2017 | -$4.85 M(-69.9%) | - | - |
| Dec 2016 | -$16.13 M(+8.1%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | -$14.93 M(-25.3%) | - | - |
| Dec 2014 | -$19.99 M(+40.8%) | - | - |
| Dec 2013 | -$14.19 M(+61.1%) | - | - |
| Dec 2012 | -$8.81 M(-4.0%) | - | - |
| Dec 2011 | -$9.18 M(-31.8%) | - | - |
| Dec 2010 | -$13.46 M(+31.7%) | - | - |
| Dec 2009 | -$10.22 M(-29.7%) | - | - |
| Dec 2008 | -$14.54 M(+29.0%) | - | - |
| Dec 2007 | -$11.28 M(+55.3%) | - | - |
| Dec 2006 | -$7.26 M(+9.8%) | - | - |
| Dec 2005 | -$6.61 M(+11.5%) | - | - |
| Dec 2004 | -$5.93 M(+35.7%) | - | - |
| Dec 2003 | -$4.37 M(+45.1%) | - | - |
| Dec 2002 | -$3.01 M(-30.9%) | - | - |
| Dec 2001 | -$4.36 M(+5.2%) | - | - |
| Dec 2000 | -$4.15 M(+17.6%) | - | - |
| Dec 1999 | -$3.53 M(+11.8%) | - | - |
| Dec 1998 | -$3.15 M(-10.8%) | - | - |
| Dec 1997 | -$3.54 M(+82.0%) | - | - |
| Dec 1996 | -$1.94 M(+31.9%) | - | - |
| Dec 1995 | -$1.47 M | - | - |
FAQ
- What is Silence Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Silence Therapeutics?
- What is Silence Therapeutics annual EBIT year-on-year change?
- What is Silence Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Silence Therapeutics?
- What is Silence Therapeutics quarterly EBIT year-on-year change?
- What is Silence Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Silence Therapeutics?
- What is Silence Therapeutics TTM EBIT year-on-year change?
What is Silence Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SLN is -$62.56 M
What is the all time high annual EBIT for Silence Therapeutics?
Silence Therapeutics all-time high annual earnings before interest & taxes is -$1.47 M
What is Silence Therapeutics annual EBIT year-on-year change?
Over the past year, SLN annual earnings before interest & taxes has changed by -$3.96 M (-6.76%)
What is Silence Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SLN is -$28.05 M
What is the all time high quarterly EBIT for Silence Therapeutics?
Silence Therapeutics all-time high quarterly earnings before interest & taxes is -$4.25 M
What is Silence Therapeutics quarterly EBIT year-on-year change?
Over the past year, SLN quarterly earnings before interest & taxes has changed by -$14.56 M (-107.93%)
What is Silence Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SLN is -$72.74 M
What is the all time high TTM EBIT for Silence Therapeutics?
Silence Therapeutics all-time high TTM earnings before interest & taxes is -$12.17 M
What is Silence Therapeutics TTM EBIT year-on-year change?
Over the past year, SLN TTM earnings before interest & taxes has changed by -$13.30 M (-22.37%)